Quantamental Technologies’s Sarepta Therapeutics SRPT Stock Holding History

Quantamental Technologies’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$327K	Buy	+2,695	New	+$305K	0.31%	125
2023 Q1	–	Sell	-1,729	Closed	-$224K	–	603
2022 Q4	$224K	Buy	+1,729	New	+$200K	0.1%	335
2022 Q3	–	Sell	-5,826	Closed	-$437K	–	659
2022 Q2	$437K	Buy	+5,826	New	+$429K	0.2%	192
2022 Q1	–	Sell	-9,981	Closed	-$899K	–	545
2021 Q4	$899K	Buy	+9,981	New	+$853K	0.46%	54
2020 Q3	–	Sell	-2,134	Closed	-$342K	–	362
2020 Q2	$342K	Buy	+2,134	New	+$290K	0.23%	141
2020 Q1	–	Sell	-2,614	Closed	-$337K	–	365
2019 Q4	$337K	Buy	2,614 +141	+6%	+$14.2K	0.17%	219
2019 Q3	$186K	Buy	+2,473	New	+$292K	0.06%	525

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Quantamental Technologies's SRPT Position: Q3 2023 in Review

Quantamental Technologies opened a new position in Sarepta Therapeutics (SRPT) in Q3 2023: 2,695 shares worth $327K. The stake represents 0.31% of the portfolio and ranks #125 among its holdings. This is a return to the name: Quantamental Technologies previously reported a position in SRPT as recently as Q4 2022.

Quantamental Technologies first reported a position in SRPT in Q3 2019 and has held it in 7 quarters since. The position peaked at $899K in Q4 2021. 394 funds tracked by Wall St. Rank hold SRPT as of Q3 2023.

Quantamental Technologies held 2,695 shares of Sarepta Therapeutics worth $327K as of Q3 2023.
Sarepta Therapeutics was a new Quantamental Technologies position in Q3 2023.
Sarepta Therapeutics made up 0.31% of Quantamental Technologies's portfolio in Q3 2023, its #125 holding.
Quantamental Technologies first reported a position in Sarepta Therapeutics in Q3 2019 and has held it in 7 quarters since.
Quantamental Technologies's Sarepta Therapeutics position peaked at $899K in Q4 2021.
394 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.